Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat

• Nadja Blagitko-Dorfs ,

  Contributed equally to this work with: Nadja Blagitko-Dorfs, Yi Jiang

  Affiliation Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany

  ⨯
• Yi Jiang ,

  Contributed equally to this work with: Nadja Blagitko-Dorfs, Yi Jiang

  Affiliations Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• Jesús Duque-Afonso,

  Affiliations Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany, Department of Pathology, Stanford University Medical Center, Stanford, California, United States of America

  ⨯
• Jan Hiller,

  Affiliation Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany

  ⨯
• Arzu Yalcin,

  Affiliations Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany, University of Freiburg, Faculty of Biology, Freiburg, Germany

  ⨯
• Gabriele Greve,

  Affiliations Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany, University of Freiburg, Faculty of Biology, Freiburg, Germany

  ⨯
• Mahmoud Abdelkarim,

  Affiliation Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany

  ⨯
• Björn Hackanson,

  Affiliation Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany

  ⨯
• Michael Lübbert

  * E-mail: michael.luebbert@uniklinik-freiburg.de

  Affiliation Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany

  ⨯